glucose, (beta-d)-isomer has been researched along with Fibromyalgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, A; Campolongo, P; Chouker, A; Eisner, C; Hauer, D; Kaufmann, I; Krauseneck, T; Richter, HP; Schelling, G; Thiel, M; Vogeser, M | 1 |
| Matsui, T; Nakamura, N; Nishino, Y; Ojima, A; Yamagishi, S | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Fibromyalgia
| Article | Year |
|---|---|
Anandamide and neutrophil function in patients with fibromyalgia.
Topics: Arachidonic Acids; Cannabinoid Receptor Modulators; Case-Control Studies; Endocannabinoids; Epinephrine; Female; Fibromyalgia; Humans; Hydrogen Peroxide; Male; Middle Aged; Neutrophils; Norepinephrine; Oxidative Stress; Phagocytosis; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB2; Research Design; Severity of Illness Index; Surveys and Questionnaires; Zymosan | 2008 |
Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibromyalgia; Gene Expression; Glucosides; Glycation End Products, Advanced; Hypoglycemic Agents; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Sodium-Glucose Transporter 2 Inhibitors | 2015 |